"
According to the latest report published by Data Bridge Market Research, the Severe Viral Lower Respiratory Tract Disease Market
The Severe Viral Lower Respiratory Tract Disease Market was valued at USD 5.21 billion in 2025 and is projected to reach USD 10.76 billion by 2033, growing at a CAGR of 9.50% from 2026 to 2033.
A talented team works strictly with...
Accelerating production speeds and lowering costs have become top mandates for global biotechnology firms, triggering significant advancements within the Viral Vaccine Cell Culture Media Market. The complex biological nature of viral replication requires incredibly precise chemical environments, making the choice of culture media one of the most critical decisions in the entire vaccine...
ROCKVILLE, MD /Sept 17, 2026 — The global viral antigens market was valued at USD 2.9 billion in 2025. It is projected to reach USD 3.1 billion in 2026 and USD 6.1 billion by 2036, expanding at a compound annual growth rate (CAGR) of 7.0%. The market is anticipated to create an absolute dollar opportunity of USD 3.0 billion between 2026 and 2036.
Note: A Fact.MR blog post...
Viral Vaccines CDMO Market to Grow at 15.3% CAGR Driven by Rising Outsourcing of Vaccine Manufacturing and Expanding Viral Vector Development Programs
Rockville, Maryland, USA – According to Fact.MR, the global viral vaccines CDMO market is projected to grow from USD 2.8 billion in 2026 to USD 11.5 billion by 2036, expanding at a CAGR of 15.3% during the forecast period....
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek